These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 26824952)

  • 21. Diagnosis and management of Staphylococcus aureus bacteraemia.
    Mitchell DH; Howden BP
    Intern Med J; 2005 Dec; 35 Suppl 2():S17-24. PubMed ID: 16271058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Staphylococcus aureus bacteremia in the surgical patient: a prospective analysis of 73 postoperative patients who developed Staphylococcus aureus bacteremia at a tertiary care facility.
    Gottlieb GS; Fowler VG; Kong LK; McClelland RS; Gopal AK; Marr KA; Li J; Sexton DJ; Glower D; Corey GR
    J Am Coll Surg; 2000 Jan; 190(1):50-7. PubMed ID: 10625232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical manifestations and outcome in Staphylococcus aureus endocarditis among injection drug users and nonaddicts: a prospective study of 74 patients.
    Ruotsalainen E; Sammalkorpi K; Laine J; Huotari K; Sarna S; Valtonen V; Järvinen A
    BMC Infect Dis; 2006 Sep; 6():137. PubMed ID: 16965625
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of seven and fourteen days of antibiotic treatment in uncomplicated Staphylococcus aureus bacteremia (SAB7): study protocol for a randomized controlled trial.
    Thorlacius-Ussing L; Andersen CØ; Frimodt-Møller N; Knudsen IJD; Lundgren J; Benfield TL
    Trials; 2019 May; 20(1):250. PubMed ID: 31046810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment duration for uncomplicated Staphylococcus aureus bacteremia to prevent relapse: analysis of a prospective observational cohort study.
    Chong YP; Moon SM; Bang KM; Park HJ; Park SY; Kim MN; Park KH; Kim SH; Lee SO; Choi SH; Jeong JY; Woo JH; Kim YS
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1150-6. PubMed ID: 23254436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Staphylococcus aureus bloodstream infections in older adults: clinical outcomes and risk factors for in-hospital mortality.
    Big C; Malani PN
    J Am Geriatr Soc; 2010 Feb; 58(2):300-5. PubMed ID: 20070420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The management and outcomes of Staphylococcus aureus bacteraemia at a South African referral hospital: A prospective observational study.
    Steinhaus N; Al-Talib M; Ive P; Boyles T; Bamford C; Davies MA; Mendelson M; Wasserman S
    Int J Infect Dis; 2018 Aug; 73():78-84. PubMed ID: 29908251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of Infectious Diseases Consultation on Clinical Outcomes of Patients with Staphylococcus aureus Bacteremia in a Community Health System.
    Turner RB; Valcarlos E; Won R; Chang E; Schwartz J
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5682-7. PubMed ID: 27401580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The associations between socioeconomic status and risk of Staphylococcus aureus bacteremia and subsequent endocarditis - a Danish nationwide cohort study.
    Oestergaard LB; Schmiegelow MD; Bruun NE; Skov RL; Petersen A; Andersen PS; Torp-Pedersen C
    BMC Infect Dis; 2017 Aug; 17(1):589. PubMed ID: 28841914
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predicting Risk of Endocarditis Using a Clinical Tool (PREDICT): Scoring System to Guide Use of Echocardiography in the Management of Staphylococcus aureus Bacteremia.
    Palraj BR; Baddour LM; Hess EP; Steckelberg JM; Wilson WR; Lahr BD; Sohail MR
    Clin Infect Dis; 2015 Jul; 61(1):18-28. PubMed ID: 25810284
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management and outcomes in patients with Staphylococcus aureus bacteremia after implementation of mandatory infectious diseases consult: a before/after study.
    Martin L; Harris MT; Brooks A; Main C; Mertz D
    BMC Infect Dis; 2015 Dec; 15():568. PubMed ID: 26666459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical identifiers of complicated Staphylococcus aureus bacteremia.
    Fowler VG; Olsen MK; Corey GR; Woods CW; Cabell CH; Reller LB; Cheng AC; Dudley T; Oddone EZ
    Arch Intern Med; 2003 Sep; 163(17):2066-72. PubMed ID: 14504120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcome of Staphylococcus aureus bacteremia in patients with eradicable foci versus noneradicable foci.
    Kim SH; Park WB; Lee KD; Kang CI; Kim HB; Oh MD; Kim EC; Choe KW
    Clin Infect Dis; 2003 Sep; 37(6):794-9. PubMed ID: 12955640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The benefits and safety of oral sequential antibiotic therapy in non-complicated and complicated Staphylococcus aureus bacteremia.
    Pérez-Rodríguez MT; Sousa A; Moreno-Flores A; Longueira R; Diéguez P; Suárez M; Lima O; Vasallo FJ; Álvarez-Fernández M; Crespo M
    Int J Infect Dis; 2021 Jan; 102():554-560. PubMed ID: 33157291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical significance and outcome of polymicrobial Staphylococcus aureus bacteremia.
    Park SY; Park KH; Bang KM; Chong YP; Kim SH; Lee SO; Choi SH; Jeong JY; Woo JH; Kim YS
    J Infect; 2012 Aug; 65(2):119-27. PubMed ID: 22410381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequency of infective endocarditis among infants and children with Staphylococcus aureus bacteremia.
    Valente AM; Jain R; Scheurer M; Fowler VG; Corey GR; Bengur AR; Sanders S; Li JS
    Pediatrics; 2005 Jan; 115(1):e15-9. PubMed ID: 15601815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Persistent Staphylococcus aureus bacteremia: incidence and outcome trends over time.
    Khatib R; Johnson LB; Sharma M; Fakih MG; Ganga R; Riederer K
    Scand J Infect Dis; 2009; 41(1):4-9. PubMed ID: 18821135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Staphylococcus aureus bacteremia in solid organ transplant recipients: evidence for improved survival when compared with nontransplant patients.
    Malinis MF; Mawhorter SD; Jain A; Shrestha NK; Avery RK; van Duin D
    Transplantation; 2012 May; 93(10):1045-50. PubMed ID: 22357175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Staphylococcus aureus bacteremia: predictors of 30-day mortality in a large cohort.
    Mylotte JM; Tayara A
    Clin Infect Dis; 2000 Nov; 31(5):1170-4. PubMed ID: 11073748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A nationwide study of comorbidity and risk of reinfection after Staphylococcus aureus bacteraemia.
    Wiese L; Mejer N; Schønheyder HC; Westh H; Jensen AG; Larsen AR; Skov R; Benfield T;
    J Infect; 2013 Sep; 67(3):199-205. PubMed ID: 23664855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.